Raymond James Financial Services Advisors, Inc. Global Blood Therapeutics, Inc. Transaction History

Raymond James Financial Services Advisors, Inc.

$73.5 Billion
Q3 2024

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 12, 2021	SELL	$37.65 - $63.77 $169,161 - $286,518	-4,493 Closed	0 $0
Q3 2020 Nov 04, 2020	BUY	$52.76 - $74.49 $7,702 - $10,875	146 Added 3.36%	4,493 $248,000
Q2 2020 Jul 17, 2020	SELL	$48.73 - $81.82 $42,638 - $71,592	-875 Reduced 16.76%	4,347 $274,000
Q1 2020 Apr 21, 2020	SELL	$41.72 - $87.2 $16,688 - $34,880	-400 Reduced 7.11%	5,222 $267,000
Q4 2019 Feb 12, 2020	SELL	$45.7 - $81.86 $14,852 - $26,604	-325 Reduced 5.46%	5,622 $447,000
Q3 2019 Nov 07, 2019	BUY	$45.35 - $57.91 $23,128 - $29,534	510 Added 9.38%	5,947 $289,000
Q2 2019 Aug 06, 2019	SELL	$52.6 - $63.29 $202,510 - $243,666	-3,850 Reduced 41.46%	5,437 $286,000
Q1 2019 May 06, 2019	SELL	$39.99 - $53.48 $49,507 - $66,208	-1,238 Reduced 11.76%	9,287 $492,000
Q4 2018 Feb 11, 2019	BUY	$31.54 - $46.67 $473 - $700	15 Added 0.14%	10,525 $432,000
Q3 2018 Nov 14, 2018	BUY	$38.0 - $51.1 $152,380 - $204,911	4,010 Added 61.69%	10,510 $399,000
Q2 2018 Jul 30, 2018	SELL	$38.7 - $50.15 $146,634 - $190,018	-3,789 Reduced 36.83%	6,500 $294,000
Q1 2018 Apr 16, 2018	BUY	$39.6 - $65.9 $101,534 - $168,967	2,564 Added 33.19%	10,289 $497,000
Q4 2017 Feb 09, 2018	BUY	$29.7 - $45.7 $9,652 - $14,852	325 Added 4.39%	7,725 $304,000
Q3 2017 Oct 26, 2017	BUY	$25.1 - $31.05 $185,740 - $229,770	7,400	7,400 $230,000

Others Institutions Holding GBT

# of Institutions

Shares Held

288K

Call Options Held

Put Options Held

View Full List

About Global Blood Therapeutics, Inc.

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

More about GBT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James Financial Services Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Raymond James Financial Services Advisors, Inc. with notifications on news.

Account